Caroline Solas-Chesneau

21PUBLICATIONS
115CO-AUTHORS
Predictive and prognostic markersEpidemiological methodsPharmacogenomicsMolecular medicineMedical biochemistry - inorganic elements and compounds
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 11, 2026
Development of a dosing algorithm integrating pharmacogenetic markers and inflammation for individualization of initial voriconazole maintenance doses.

|Sep 11, 2026
Real-World Experience With Lenacapavir and/or Fostemsavir as Emerging Therapies for the Management of Multidrug-Resistant HIV-1 in Southeastern France.

|Jul 03, 2026
Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

|Feb 16, 2026
How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19.

Inès Ben Ghezala, Nathan Peiffer-Smadja, Caroline Solas

|Oct 28, 2025
Biomarkers of Gamma-Hydroxybutyric Acid (GHB) Exposure: A Comprehensive Review of Analytical and Forensic Advances.

Alice Voisin, Caroline Solas-Chesneau, Anne-Laure Pélissier-Alicot

|Aug 18, 2025
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study.

Nadège Néant, Minh P Lê, Stéphane Bouchet

Pageof 4

Frequent Collaborators

4 joint publications

Nadège Néant

4 joint publications

Minh Patrick Lê

3 joint publications

Florian Lemaitre

3 joint publications

Gilles Peytavin